Tensha Therapeutics

Tensha is staking a claim on drugging bromodomains as an innovative epigenetic approach to novel anti-cancer agents.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rohn, J. Tensha Therapeutics. Nat Biotechnol 30, 305 (2012). https://doi.org/10.1038/nbt0412-305

Download citation

Further reading